Brind.
  1. Major pharmaceutical companies including Sanofi, Regeneron, Roche, Eli Lilly, Biogen, and Gilead are maintaining alliances and competing across key therapeutic areas like ophthalmology, immunology, and oncology.
  2. Ralph Lauren, Biogen, and Zebra Technologies are currently under scrutiny as mid-cap stocks.

Ariel Small Cap Value Strategy highlighted Zebra Technologies stock on August 22, 2025.

1 report, 1 independent Updated Aug 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Ariel Small Cap Value Strategy highlighted Zebra Technologies stock on August 22, 2025.

Who's involved

What this event is mainly about
Ariel InvestmentsZebra Technologies

Keep exploring

Part of

Ralph Lauren, Biogen, and Zebra Technologies are currently under scrutiny as mid-cap stocks.

Also in this story

All 3 developments

Within Major pharmaceutical companies including Sanofi, Regeneron, Roche, Eli Lilly, Biogen, and Gilead are maintaining alliances and competing across key therapeutic areas like ophthalmology, immunology, and oncology.

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • Insider MonkeyAriel Small Cap Value Added Zebra Technologies (ZBRA) to Its Portfolio in Q2 Ariel Investments, an investment management company, released its “Ariel Small Cap Value Strategy” second-quarter 2025 inv